Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Biliary Tract Neoplasms × Cetuximab × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 116 Head and Neck Neoplasms 81 Squamous Cell Carcinoma of Head and Neck 77 Carcinoma, Non-Small-Cell Lung 50 Colonic Neoplasms 37 Rectal Neoplasms 33 Neoplasm Metastasis 28 Neoplasms 25 Pancreatic Neoplasms 20 Lung Neoplasms 16 Carcinoma, Squamous Cell 15 Stomach Neoplasms 14 Esophageal Neoplasms 13 Tongue Neoplasms 10 Recurrence 9 Laryngeal Neoplasms 9 Breast Neoplasms 9 Salivary Gland Neoplasms 8 Mouth Neoplasms 8 Esophageal Squamous Cell Carcinoma 8 Adenocarcinoma Of Esophagus 8 Adenocarcinoma of Lung 7 Neoplasms, Squamous Cell 6 Hypopharyngeal Neoplasms 6 Carcinoma 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Oropharyngeal Neoplasms 5 Nasopharyngeal Carcinoma 5 Carcinoma, Renal Cell 5 Precancerous Conditions 4

Interventions

Gemcitabine 30 Cisplatin 19 Capecitabine 16 Oxaliplatin 12 Leucovorin 10 Fluorouracil 10 S 1 (combination) 8 pembrolizumab 7 tremelimumab 5 durvalumab 5 Nivolumab 5 lenvatinib 4 Irinotecan 4 Bevacizumab 4 titanium silicide 3 atezolizumab 3 Radiofrequency Ablation 3 zanidatamab 2 vandetanib 2 trametinib 2 irinotecan sucrosofate 2 derazantinib 2 camrelizumab 2 binimetinib 2 apatinib 2 Trastuzumab 2 Tegafur 2 Docetaxel 2 Cryosurgery 2 Cholangiopancreatography, Endoscopic Retrograde 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01267344 2016-05-04

BTC

National Health Research Institutes, Taiwan

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡